Andrew Komjathy

Corporate Officer/Principal bei ASTRIA THERAPEUTICS, INC.

Vermögen: 947 $ am 31.05.2024

61 Jahre

Health Technology

Consumer Services

Aktive Positionen von Andrew Komjathy

Unternehmen	Position	Beginn	Ende
ASTRIA THERAPEUTICS, INC.	Corporate Officer/Principal	25.09.2019	-

Unternehmen	Position	Beginn	Ende
Alkermes, Inc. Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA.	Vertrieb & Marketing	01.05.2014	01.11.2018
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Vertrieb & Marketing	01.01.2012	01.01.2014
Shire Human Genetic Therapies, Inc. Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.	Corporate Officer/Principal	01.01.2005	01.01.2012

The Leonard N Stern School of Business	Masters Business Admin
Bucknell University	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	2
Sales & Marketing	2
Masters Business Admin	1

Sektoral

Health Technology	5
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ASTRIA THERAPEUTICS, INC.	Health Technology

Private Unternehmen	3
Alkermes, Inc. Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA.	Health Technology
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology
Shire Human Genetic Therapies, Inc. Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.	Health Technology